<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-10-29T23:31:47+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://www.medicinanews.it/inibitori-tnf-alfa-glaucoma-rischio/369061/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T23:41:01+01:00</news:publication_date><news:title>Gli inibitori del TNF-alfa riducono il rischio di glaucoma: cosa dice la ricerca</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/monitoraggio-adhd-lungo-termine-parametri/369058/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T23:40:43+01:00</news:publication_date><news:title>Monitoraggio a lungo termine dell&#8217;ADHD: i parametri clinici da controllare regolarmente</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/vaccini-anticancro-ostacoli-accesso/369055/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T23:38:35+01:00</news:publication_date><news:title>I vaccini anticancro in arrivo: come superare gli ostacoli per raggiungere i pazienti</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/artrite-reumatoide-donne-disparita-genere/369052/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T23:37:24+01:00</news:publication_date><news:title>Artrite reumatoide nelle donne e negli uomini: perché gli esiti clinici rimangono diseguali nonostante gli stessi obiettivi terapeutici</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/prezzi-farmaci-nuovi-aumento-35-percento/369049/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T23:36:34+01:00</news:publication_date><news:title>Farmaci nuovi sul mercato: i prezzi salgono del 35% in tre anni al netto di inflazione e riduzioni commerciali</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/farmaci-oncologia-gsk-sei-antitumorali/369046/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T23:35:10+01:00</news:publication_date><news:title>GSK ritorna in oncologia con sei nuovi farmaci: la strategia del rilancio terapeutico</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/pathos-ai-drug-discovery-finanziamento/369043/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T22:22:51+01:00</news:publication_date><news:title>Pathos raccoglie 237 milioni di dollari in Serie E: la partnership con Bristol Myers Squibb e Tempus AI accelera la scoperta di nuovi farmaci</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/povetacicept-kidney-disease-fda-infection-risk/369040/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T16:59:11+01:00</news:publication_date><news:title>Il farmaco Vertex per le malattie renali sotto esame per il rischio infettivo prima della decisione della FDA</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/divarasib-cancro-polmoni-roche/369037/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T16:22:55+01:00</news:publication_date><news:title>Divarasib, la nuova opzione terapeutica di Roche per il cancro polmonare KRAS-mutato</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/cannabis-gravidanza-rischi-neurosviluppistici/369034/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T11:47:11+01:00</news:publication_date><news:title>Cannabis in gravidanza: i rischi per lo sviluppo neurologico del feto</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/infezione-hmpv-morbidita-grave/369031/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T10:45:09+01:00</news:publication_date><news:title>Metapneumovirus umano: come l&#8217;infezione aumenta il rischio di complicanze gravi nei pazienti ricoverati</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/cancro-endometriale-avanzato-trattamento-adc/369028/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T10:18:24+01:00</news:publication_date><news:title>Il farmaco ADC di Merck e Kelun-Biotech riduce la mortalità nel cancro endometriale avanzato</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/oppioidi-mal-di-schiena-dipendenza-studio/369025/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T09:44:09+01:00</news:publication_date><news:title>Oppioidi nel mal di schiena cronico: lo studio che conferma i rischi di dipendenza</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/pbm-audit-farmacie-indipendenti-indagine/369022/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T08:59:14+01:00</news:publication_date><news:title>Le farmacie indipendenti nella morsa degli audit dei PBM: quando i controlli diventano punizione</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/terapie-geniche-personalizzate-malattie-rare-fda/369019/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T08:55:14+01:00</news:publication_date><news:title>FDA accelera l&#8217;approvazione delle terapie geniche personalizzate per le malattie rare</news:title></news:news></url>
<url><loc>https://www.medicinanews.it/idrosadenite-suppurativa-linee-guida/369016/</loc><news:news><news:publication><news:name>Medicinanews.it</news:name><news:language>it</news:language></news:publication><news:publication_date>2026-10-29T08:43:15+01:00</news:publication_date><news:title>Idrosadenite suppurativa: le nuove linee guida per una gestione efficace della malattia</news:title></news:news></url>
</urlset>
